• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中风与药物递送——缺血性血脑屏障的体外模型

Stroke and Drug Delivery--In Vitro Models of the Ischemic Blood-Brain Barrier.

作者信息

Tornabene Erica, Brodin Birger

机构信息

Section of Pharmaceutical Design and Drug Delivery, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2100 Copenhagen, Denmark.

Section of Pharmaceutical Design and Drug Delivery, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2100 Copenhagen, Denmark.

出版信息

J Pharm Sci. 2016 Feb;105(2):398-405. doi: 10.1016/j.xphs.2015.11.041.

DOI:10.1016/j.xphs.2015.11.041
PMID:26869407
Abstract

Stroke is a major cause of death and disability worldwide. Both cerebral hypoperfusion and focal cerebral infarcts are caused by a reduction of blood flow to the brain, leading to stroke and subsequent brain damage. At present, only few medical treatments of stroke are available, with the Food and Drug Administration-approved tissue plasminogen activator for treatment of acute ischemic stroke being the most prominent example. A large number of potential drug candidates for treatment of ischemic brain tissue have been developed and subsequently failed in clinical trials. A deeper understanding of permeation pathways across the barrier in ischemic and postischemic brain endothelium is important for development of new medical treatments. The blood-brain barrier, that is, the endothelial monolayer lining the brain capillaries, changes properties during an ischemic event. In vitro models of the blood-brain barrier are useful tools to investigate the effects of induced ischemia under controlled conditions. In the present mini review, we aim to give a brief overview of the in vitro models of ischemia. Special focus is given to the expression of uptake and efflux transport pathways in the ischemic and postischemic endothelium. Finally, we will point toward future challenges within the field of in vitro models of brain ischemia.

摘要

中风是全球范围内导致死亡和残疾的主要原因。脑灌注不足和局灶性脑梗死均由脑血流量减少引起,进而导致中风及随后的脑损伤。目前,中风的药物治疗方法寥寥无几,美国食品药品监督管理局批准的用于治疗急性缺血性中风的组织纤溶酶原激活剂是最突出的例子。大量用于治疗缺血性脑组织的潜在候选药物已被研发出来,但随后在临床试验中失败。深入了解缺血及缺血后脑内皮屏障的渗透途径对于开发新的医学治疗方法至关重要。血脑屏障,即衬于脑毛细血管的内皮单层,在缺血事件期间会改变其特性。血脑屏障的体外模型是在可控条件下研究诱导缺血影响的有用工具。在本综述中,我们旨在简要概述缺血的体外模型。特别关注缺血及缺血后内皮中摄取和外排转运途径的表达。最后,我们将指出脑缺血体外模型领域未来面临的挑战。

相似文献

1
Stroke and Drug Delivery--In Vitro Models of the Ischemic Blood-Brain Barrier.中风与药物递送——缺血性血脑屏障的体外模型
J Pharm Sci. 2016 Feb;105(2):398-405. doi: 10.1016/j.xphs.2015.11.041.
2
Brain endothelial cell specific integrins and ischemic stroke.脑内皮细胞特异性整合素与缺血性中风。
Expert Rev Neurother. 2014 Nov;14(11):1287-92. doi: 10.1586/14737175.2014.964210. Epub 2014 Sep 29.
3
Blood-brain barrier KCa3.1 channels: evidence for a role in brain Na uptake and edema in ischemic stroke.血脑屏障KCa3.1通道:在缺血性脑卒中脑钠摄取和水肿中作用的证据
Stroke. 2015 Jan;46(1):237-44. doi: 10.1161/STROKEAHA.114.007445. Epub 2014 Dec 4.
4
Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in mice.重组组织型纤溶酶原激活剂通过血管内皮生长因子介导的内皮细胞内吞作用,在小鼠脑缺血期间短暂增强血脑屏障通透性。
J Cereb Blood Flow Metab. 2015 Dec;35(12):2021-31. doi: 10.1038/jcbfm.2015.167. Epub 2015 Jul 29.
5
Insulin-Like Growth Factor (IGF)-I Modulates Endothelial Blood-Brain Barrier Function in Ischemic Middle-Aged Female Rats.胰岛素样生长因子(IGF)-I调节中年雌性缺血性大鼠的内皮血脑屏障功能。
Endocrinology. 2016 Jan;157(1):61-9. doi: 10.1210/en.2015-1840. Epub 2015 Nov 10.
6
Drug delivery systems for the treatment of ischemic stroke.用于治疗缺血性中风的药物输送系统。
Pharm Res. 2013 Oct;30(10):2429-44. doi: 10.1007/s11095-012-0959-2. Epub 2013 Jan 10.
7
Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.重组组织型纤溶酶原激活剂在短暂性局灶性脑缺血后通过基质金属蛋白酶-9 非依赖性途径诱导血脑屏障破裂。
Eur J Neurosci. 2011 Oct;34(7):1085-92. doi: 10.1111/j.1460-9568.2011.07843.x. Epub 2011 Sep 6.
8
Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.组织型纤溶酶原激活剂给药时间对短暂性脑缺血性中风大鼠血脑屏障通透性及出血性转化的影响
J Neurol Sci. 2014 Dec 15;347(1-2):148-54. doi: 10.1016/j.jns.2014.09.036. Epub 2014 Sep 28.
9
Prevention of rt-PA induced blood-brain barrier component degradation by the poly(ADP-ribose)polymerase inhibitor PJ34 after ischemic stroke in mice.聚(ADP-核糖)聚合酶抑制剂 PJ34 对缺血性脑卒中后 rt-PA 诱导的血脑屏障成分降解的预防作用。
Exp Neurol. 2013 Oct;248:416-28. doi: 10.1016/j.expneurol.2013.07.007. Epub 2013 Jul 20.
10
Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.重组 ADAMTS13 可减少小鼠中风后组织型纤溶酶原激活物诱导的出血。
Ann Neurol. 2013 Feb;73(2):189-98. doi: 10.1002/ana.23762. Epub 2012 Dec 31.

引用本文的文献

1
Ultrasound trapping and navigation of microrobots in the mouse brain vasculature.超声捕获和导航微机器人在小鼠脑脉管系统。
Nat Commun. 2023 Sep 21;14(1):5889. doi: 10.1038/s41467-023-41557-3.
2
A Novel Isotope-labeled Small Molecule Probe CC12 for Anti-glioma via Suppressing LYN-mediated Progression and Activating Apoptosis Pathways.一种新型同位素标记小分子探针 CC12 通过抑制 LYN 介导的进展和激活细胞凋亡途径来抗神经胶质瘤。
Int J Biol Sci. 2023 Jun 19;19(10):3209-3225. doi: 10.7150/ijbs.82266. eCollection 2023.
3
[From the laboratory to the clinic in acute ischaemic stroke. In vitro and in vivo experimental models].
[从实验室到急性缺血性中风的临床。体外和体内实验模型]
Rev Neurol. 2022 Nov 1;75(9):283-293. doi: 10.33588/rn.7509.2022268.
4
Protective effect of miR-33-5p on the M1/M2 polarization of microglia and the underlying mechanism.miR-33-5p 对小胶质细胞 M1/M2 极化的保护作用及其机制。
Bioengineered. 2022 Apr;13(4):10774-10785. doi: 10.1080/21655979.2022.2061285.
5
A Review on Preclinical Models of Ischemic Stroke: Insights Into the Pathomechanisms and New Treatment Strategies.缺血性脑卒中的临床前模型综述:对发病机制和新治疗策略的深入了解。
Curr Neuropharmacol. 2022 Aug 3;20(9):1667-1686. doi: 10.2174/1570159X19666210907092928.
6
Extracellular Vesicles Derived from a Human Brain Endothelial Cell Line Increase Cellular ATP Levels.人脑血管内皮细胞来源的细胞外囊泡增加细胞内 ATP 水平。
AAPS PharmSciTech. 2021 Jan 3;22(1):18. doi: 10.1208/s12249-020-01892-w.
7
Transport of ultrasmall gold nanoparticles (2 nm) across the blood-brain barrier in a six-cell brain spheroid model.六细胞脑球体模型中 2nm 超小金纳米颗粒的血脑屏障转运。
Sci Rep. 2020 Oct 22;10(1):18033. doi: 10.1038/s41598-020-75125-2.
8
Multicellular 3D Neurovascular Unit Model for Assessing Hypoxia and Neuroinflammation Induced Blood-Brain Barrier Dysfunction.用于评估缺氧和神经炎症引起的血脑屏障功能障碍的多细胞 3D 神经血管单元模型。
Sci Rep. 2020 Jun 17;10(1):9766. doi: 10.1038/s41598-020-66487-8.
9
In-vitro blood-brain barrier models for drug screening and permeation studies: an overview.用于药物筛选和渗透研究的体外血脑屏障模型:综述
Drug Des Devel Ther. 2019 Oct 18;13:3591-3605. doi: 10.2147/DDDT.S218708. eCollection 2019.
10
Acetyl-11-keto-β-boswellic acid (AKBA) Attenuates Oxidative Stress, Inflammation, Complement Activation and Cell Death in Brain Endothelial Cells Following OGD/Reperfusion.乙酰-11-酮-β-乳香酸(AKBA)可减轻脑内皮细胞 OGD/再灌注后氧化应激、炎症、补体激活和细胞死亡。
Neuromolecular Med. 2019 Dec;21(4):505-516. doi: 10.1007/s12017-019-08569-z. Epub 2019 Sep 12.